Abstract
Inherited metabolic disorders are becoming more important with the increasing availability of diagnostic methods and therapies for these conditions. The radiologist has become an important link in making the diagnosis or collaborating with the specialist centre to diagnose these disorders and monitor effects of therapy. The modes of presentation, disease-specific groups, classic radiological features and investigations are explored in this article to try and give the general radiologist some crucial background knowledge. The following presentations are covered: acute intoxication, hypoglycaemia, developmental delay and storage features. Specific groups of disorders covered are the abnormalities of intermediary metabolism, disorders of fatty acid oxidation and ketogenesis, mitochondrial disorders, lysosomal storage disorders, and, briefly, other groups such as peroxisomal disorders, disorders of glycosylation, and creatine synthesis disorders. New advances and the demands for monitoring are also briefly explored.
Similar content being viewed by others
References
Garrod A (1902) The incidence of alkaptonuria: a study in chemical individuality. Lancet 2:1616–1620
Cleary MA, Walter JH, Wraith JE et al (1995) Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change. J Pediatr 127:251–255
Santra S, Baumann U (2008) Experience of nitisinone for the pharmacological treatment of hereditary tyrosinaemia type 1. Expert Opin Pharmacother 9:1229–1236
Sener RN (2005) Tyrosinemia: computed tomography, magnetic resonance imaging, diffusion magnetic resonance imaging, and proton spectroscopy findings in the brain. J Comput Assist Tomogr 29:323–325
Perrone A, Impara L, Bruni A et al (2005) Radiographic and MRI findings in ochronosis. Radiol Med (Torino) 110:349–358
Gaines JJ Jr, Pai GM (1987) Cardiovascular ochronosis. Arch Pathol Lab Med 111:991–994
Lu CY, Hou JW, Wang PJ et al (1996) Homocystinuria presenting as fatal common carotid artery occlusion. Pediatr Neurol 15:159–162
Herrmann M, Widmann T, Herrmann W (2005) Homocysteine – a newly recognised risk factor for osteoporosis. Clin Chem Lab Med 43:1111–1117
Dublin AB, Hald JK, Wootton-Gorges SL (2002) Isolated sulfite oxidase deficiency: MR imaging features. AJNR 23:484–485
Hoffmann C, Ben Zeev B, Anikster Y et al (2007) Magnetic resonance imaging and magnetic resonance spectroscopy in isolated sulfite oxidase deficiency. J Child Neurol 22:1214–1221
Schonberger S, Schweiger B, Schwahn B et al (2004) Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol Genet Metab 82:69–75
Parmar H, Sitoh YY, Ho L (2004) Maple syrup urine disease: diffusion-weighted and diffusion-tensor magnetic resonance imaging findings. J Comput Assist Tomogr 28:93–97
Jan W, Zimmerman RA, Wang ZJ et al (2003) MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation. Neuroradiology 45:393–399
Zinnanti WJ, Lazovic J, Housman C et al (2007) Mechanism of age-dependent susceptibility and novel treatment strategy in glutaric acidemia type I. J Clin Invest 117:3258–3270
Brismar J, Ozand PT (1995) CT and MR of the brain in glutaric acidemia type I: a review of 59 published cases and a report of 5 new patients. AJNR 16:675–683
Whelan DT, Hill R, Ryan ED et al (1979) L-Glutaric acidemia: investigation of a patient and his family. Pediatrics 63:88–93
Barbot C, Fineza I, Diogo L et al (1997) L-2-Hydroxyglutaric aciduria: clinical, biochemical and magnetic resonance imaging in six Portuguese pediatric patients. Brain Dev 19:268–273
Clarke NF, Andrews I, Carpenter K et al (2003) D-2-hydroxyglutaric aciduria: a case with an intermediate phenotype and prenatal diagnosis of two affected fetuses. Am J Med Genet 120A:523–527
van der Knaap MS, Jakobs C, Hoffmann GF et al (1999) D-2-hydroxyglutaric aciduria: further clinical delineation. J Inherit Metab Dis 22:404–413
Kwong KL, Mak T, Fong CM et al (2002) D-2-Hydroxyglutaric aciduria and subdural haemorrhage. Acta Paediatr 91:716–718
Sugita K, Kakinuma H, Okajima Y et al (1995) Clinical and MRI findings in a case of D-2-hydroxyglutaric aciduria. Brain Dev 17:139–141
Talkhani IS, Saklatvala J, Dwyer J (2000) D-2-hydroxyglutaric aciduria in association with spondyloenchondromatosis. Skeletal Radiol 29:289–292
Honey EM, van Rensburg M, Knoll DP et al (2003) Spondyloenchondromatosis with D-2-hydroxyglutaric aciduria: a report of a second patient with this unusual combination. Clin Dysmorphol 12:95–99
Kjaergaard S, Graem N, Larsen T et al (1998) Recurrent fetal polycystic kidneys associated with glutaric aciduria type II. APMIS 106:1188–1193
Takanashi J, Fujii K, Sugita K et al (1999) Neuroradiologic findings in glutaric aciduria type II. Pediatr Neurol 20:142–145
Firat AK, Karakas HM, Yakinci C (2006) Magnetic resonance spectroscopic characteristics of glutaric aciduria type II. Dev Med Child Neurol 48:847–850
Brismar J, Ozand PT (1994) CT and MR of the brain in disorders of the propionate and methylmalonate metabolism. AJNR 15:1459–1473
Yalcinkaya C, Dincer A, Gunduz E et al (1999) MRI and MRS in HMG-CoA lyase deficiency. Pediatr Neurol 20:375–380
Ozand PT, Rashed M, Gascon GG et al (1994) 3-Ketothiolase deficiency: a review and four new patients with neurologic symptoms. Brain Dev 16 [Suppl]:38–45
Leijser LM, de Vries LS, Rutherford MA et al (2007) Cranial ultrasound in metabolic disorders presenting in the neonatal period: characteristic features and comparison with MR imaging. AJNR 28:1223–1231
Takeoka M, Soman TB, Shih VE et al (2001) Carbamyl phosphate synthetase 1 deficiency: a destructive encephalopathy. Pediatr Neurol 24:193–199
Gungor S, Akinci A, Firat AK et al (2008) Neuroimaging findings in hyperargininemia. J Neuroimaging 18:457–462
Roze E, Azuar C, Menuel C et al (2007) Usefulness of magnetic resonance spectroscopy in urea cycle disorders. Pediatr Neurol 37:222–225
Albayram S, Murphy KJ, Gailloud P et al (2002) CT findings in the infantile form of citrullinemia. AJNR 23:334–336
Wong YC, Au WL, Xu M et al (2007) Magnetic resonance spectroscopy in adult-onset citrullinemia: elevated glutamine levels in comatose patients. Arch Neurol 64:1034–1037
Valanne L, Ketonen L, Majander A et al (1998) Neuroradiologic findings in children with mitochondrial disorders. AJNR 19:369–377
Chu BC, Terae S, Takahashi C et al (1999) MRI of the brain in the Kearns-Sayre syndrome: report of four cases and a review. Neuroradiology 41:759–764
Kapeller P, Fazekas F, Offenbacher H et al (1996) Magnetic resonance imaging and spectroscopy of progressive cerebral involvement in Kearns Sayre syndrome. J Neurol Sci 135:126–130
Hirano M, Silvestri G, Blake DM et al (1994) Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 44:721–727
Gordon N (2006) Alpers syndrome: progressive neuronal degeneration of children with liver disease. Dev Med Child Neurol 48:1001–1003
Afifi AK, Sato Y, Waziri MH et al (1990) Computed tomography and magnetic resonance imaging of the brain in Hurler’s disease. J Child Neurol 5:235–241
Miebach E (2005) Enzyme replacement therapy in mucopolysaccharidosis type I. Acta Paediatr Suppl 94:58–60
Bembi B, Ciana G, Mengel E et al (2002) Bone complications in children with Gaucher disease. Br J Radiol 75 [Suppl 1]:A37–A44
Elstein D, Abrahamov A, Dweck A et al (2002) Gaucher disease: pediatric concerns. Paediatr Drugs 4:417–426
Hermann G, Pastores GM, Abdelwahab IF (1997) Gaucher disease: assessment of skeletal involvement and therapeutic responses to enzyme replacement. Skeletal Radiol 26:687–696
McCormack PL, Goa KL (2003) Miglustat. Drugs 63:2427–2434
McHugh K, Olsen OE, Vellodi A (2004) Gaucher disease in children: radiology of non-central nervous system manifestations. Clin Radiol 59:117–123
Vom DS, Poll L, Di Rocco M et al (2006) Evidence-based recommendations for monitoring bone disease and the response to enzyme replacement therapy in Gaucher patients. Curr Med Res Opin 22:1045–1064
Seto T, Kono K, Morimoto K et al (2001) Brain magnetic resonance imaging in 23 patients with mucopolysaccharidoses and the effect of bone marrow transplantation. Ann Neurol 50:79–92
Vedolin L, Schwartz IV, Komlos M et al (2007) Brain MRI in mucopolysaccharidosis: effect of aging and correlation with biochemical findings. Neurology 69:917–924
Wilken B, Dechent P, Hanefeld F et al (2008) Proton MRS of a child with Sandhoff disease reveals elevated brain hexosamine. Eur J Paediatr Neurol 12:56–60
Yamada H, Ohya M, Higeta T et al (1987) Craniosynostosis and hydrocephalus in I-cell disease (mucolipidosis II). Childs Nerv Sys 3:55–57
Rodrigues R, Marchiori E, Muller NL (2004) Niemann-Pick disease: high-resolution CT findings in two siblings. J Comput Assist Tomogr 28:52–54
Palmeri S, Battisti C, Federico A et al (1994) Hypoplasia of the corpus callosum in Niemann-Pick type C disease. Neuroradiology 36:20–22
Tedeschi G, Bonavita S, Barton NW et al (1998) Proton magnetic resonance spectroscopic imaging in the clinical evaluation of patients with Niemann-Pick type C disease. J Neurol Neurosurg Psychiatry 65:72–79
Lidove O, Klein I, Lelievre JD et al (2006) Imaging features of Fabry disease. AJR 186:1184–1191
Choi S, Enzmann DR (1993) Infantile Krabbe disease: complementary CT and MR findings. AJNR 14:1164–1166
Kim TS, Kim IO, Kim WS et al (1997) MR of childhood metachromatic leukodystrophy. AJNR 18:733–738
Kruse B, Hanefeld F, Christen HJ et al (1993) Alterations of brain metabolites in metachromatic leukodystrophy as detected by localized proton magnetic resonance spectroscopy in vivo. J Neurol 241:68–74
Boxer RA, Fishman M, LaCorte MA et al (1986) Cardiac MR imaging in Pompe disease. J Comput Assist Tomogr 10:857–859
van der Knaap MS, Verhoeven NM, Maaswinkel-Mooij P et al (2000) Mental retardation and behavioral problems as presenting signs of a creatine synthesis defect. Ann Neurol 47:540–543
Conflict of interest
The author is a medical advisor for some of the companies developing and marketing ultra-orphan drugs, is an invited speaker at some of their conferences, and has received travel grants and honoraria from them.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hendriksz, C.J. Inborn errors of metabolism for the diagnostic radiologist. Pediatr Radiol 39, 211–220 (2009). https://doi.org/10.1007/s00247-008-1072-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-008-1072-x